Zevra Therapeutics, Inc. (ZVRA)
10.12
+0.13
(+1.30%)
USD |
NASDAQ |
Oct 05, 09:34
Zevra Therapeutics Price : 10.12 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 10.24 | 10.24 | 9.845 | 9.99 | 951870.0 |
| Oct 01, 2026 | 10.91 | 10.96 | 10.15 | 10.18 | 1.301M |
| Sep 30, 2026 | 11.37 | 11.38 | 10.94 | 10.97 | 1.818M |
| Sep 29, 2026 | 11.28 | 11.50 | 11.20 | 11.34 | 1.347M |
| Sep 28, 2026 | 11.01 | 11.36 | 10.89 | 11.30 | 751309.0 |
| Sep 25, 2026 | 11.29 | 11.30 | 11.01 | 11.04 | 678558.0 |
| Sep 24, 2026 | 11.28 | 11.32 | 11.06 | 11.26 | 593987.0 |
| Sep 23, 2026 | 11.58 | 11.58 | 11.15 | 11.32 | 735894.0 |
| Sep 22, 2026 | 11.85 | 11.88 | 11.51 | 11.58 | 601196.0 |
| Sep 21, 2026 | 11.72 | 11.88 | 11.52 | 11.67 | 714955.0 |
| Sep 18, 2026 | 11.76 | 11.93 | 11.52 | 11.61 | 1.482M |
| Sep 17, 2026 | 11.96 | 12.29 | 11.79 | 11.84 | 1.591M |
| Sep 16, 2026 | 11.65 | 11.84 | 11.61 | 11.80 | 795113.0 |
| Sep 15, 2026 | 12.34 | 12.34 | 11.52 | 11.65 | 916554.0 |
| Sep 14, 2026 | 12.03 | 12.18 | 11.96 | 12.05 | 621969.0 |
| Sep 11, 2026 | 12.23 | 12.30 | 11.96 | 12.01 | 583005.0 |
| Sep 10, 2026 | 11.99 | 12.23 | 11.88 | 12.06 | 675501.0 |
| Sep 09, 2026 | 12.79 | 12.79 | 12.02 | 12.04 | 923591.0 |
| Sep 08, 2026 | 12.24 | 12.90 | 12.18 | 12.68 | 1.140M |
| Sep 04, 2026 | 12.44 | 12.65 | 12.20 | 12.40 | 1.030M |
| Sep 03, 2026 | 12.42 | 12.55 | 12.26 | 12.54 | 890552.0 |
| Sep 02, 2026 | 12.07 | 12.39 | 12.04 | 12.30 | 1.348M |
| Sep 01, 2026 | 11.61 | 12.11 | 11.56 | 12.06 | 1.039M |
| Aug 31, 2026 | 11.56 | 11.81 | 11.39 | 11.74 | 818901.0 |
| Aug 28, 2026 | 11.74 | 11.80 | 11.54 | 11.56 | 617862.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Innoviva, Inc. | 20.51 |
| Johnson & Johnson | 254.60 |
| Ligand Pharmaceuticals, Inc. | 303.08 |
| Collegium Pharmaceutical, Inc. | 22.16 |
| Xeris Biopharma Holdings, Inc. | 9.25 |
Price Related Metrics
| PE Ratio | 10.92 |
| PS Ratio | 4.418 |
| Price to Book Value | 2.759 |
| Price to Free Cash Flow | 18.43 |
| Earnings Yield | 9.16% |
| Market Cap | 600.54M |
| Operating PE Ratio | 15.39 |
| Normalized PE Ratio | 8.921 |